BEMJ MENU
License
The Jurnal Riset Kefarmasian Indonesia (JRKI) is committed to promoting open access, the dissemination of scientific knowledge, and the responsible sharing of scholarly research in pharmaceutical sciences and related disciplines.
Articles published in The Jurnal Riset Kefarmasian Indonesia are made available under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0).
This license allows readers and other users to access, share, reproduce, distribute, and adapt published materials for non-commercial purposes, provided that appropriate attribution is given to the original authors and the journal, and that adapted materials are distributed under the same license.
License Information:
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
https://creativecommons.org/licenses/by-nc-sa/4.0/
1. Copyright Ownership
Authors who publish their manuscripts in The Jurnal Riset Kefarmasian Indonesia retain the copyright to their scholarly works.
By submitting and publishing their manuscripts in the journal, authors grant The Jurnal Riset Kefarmasian Indonesia the right of first publication.
The published articles are simultaneously distributed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the right to use, share, and distribute their published works in accordance with the applicable licensing terms and publication agreements.
2. Permissions Granted by the License
Under the CC BY-NC-SA 4.0 license, users are free to:
Share
Copy and redistribute published articles in any medium or format for non-commercial purposes.
This includes downloading, printing, storing, and sharing articles through academic websites, institutional repositories, educational platforms, and other non-commercial scholarly communication channels.
Adapt
Remix, transform, translate, and build upon published materials for non-commercial purposes.
Users may create adaptations or derivative works, provided that the original authors are properly acknowledged and the resulting materials are distributed under the same or a compatible license as permitted by the applicable Creative Commons terms.
These permissions remain valid as long as users comply with the conditions of the license.
3. Conditions of Use
The reuse and distribution of published articles are subject to the following conditions:
Attribution (BY)
Users must provide appropriate acknowledgment of the original authors and the initial publication in The Jurnal Riset Kefarmasian Indonesia.
Attribution should include, where available:
-
Names of the original authors.
-
Title of the published article.
-
Name of the journal.
-
Year of publication.
-
Digital Object Identifier (DOI) or original article URL.
-
Reference or link to the applicable Creative Commons license.
Users must also indicate whether any modifications have been made to the original material.
Attribution must not imply that the original authors or the journal endorse the user or the particular use of the material.
NonCommercial (NC)
Published materials may not be used primarily for commercial advantage or monetary compensation under the permissions granted by this license.
Commercial uses requiring permission beyond the license terms must be separately authorized by the relevant copyright holder.
ShareAlike (SA)
If users remix, transform, or build upon published materials, they must distribute their adaptations under the same Creative Commons license or another license permitted by the applicable ShareAlike provisions.
This requirement helps preserve the availability of adapted scholarly materials under compatible open licensing conditions.
No Additional Restrictions
Users may not impose additional legal terms or technological measures that legally restrict others from exercising the rights permitted by the license.
4. Authors' Rights
Authors publishing in The Jurnal Riset Kefarmasian Indonesia retain the following rights, subject to the journal's publication agreement and applicable license:
-
Retain copyright ownership of their original scholarly works.
-
Grant the journal the right of first publication.
-
Share and distribute their published articles through personal websites, institutional repositories, and non-commercial academic platforms.
-
Enter into separate, additional non-exclusive distribution arrangements, provided that the original publication in the journal is properly acknowledged and the arrangements are consistent with applicable rights and obligations.
-
Use their published works for academic teaching, research, scholarly communication, and other permitted purposes.
-
Deposit preprints, accepted manuscripts, or published versions in appropriate repositories, in accordance with the journal's self-archiving policy and applicable licensing terms.
The journal encourages authors to disseminate their research responsibly to increase the visibility, accessibility, and potential impact of their scholarly contributions.
5. Third-Party Materials
The Creative Commons license applies to the content for which the authors or other relevant rights holders have granted the necessary licensing permissions.
Third-party materials, including photographs, illustrations, figures, tables, datasets, or other copyrighted content, may be subject to separate licensing conditions when explicitly indicated.
Authors are responsible for obtaining the necessary permissions for the use and publication of third-party copyrighted materials.
Readers wishing to reuse such materials must comply with the applicable copyright and licensing requirements.
6. Open Access and Research Dissemination
The Jurnal Riset Kefarmasian Indonesia provides immediate open access to published scholarly content to support the global exchange of scientific knowledge.
Readers are not required to pay subscription fees, article access fees, or download charges to read published articles.
The journal believes that open access contributes to the advancement of scientific research, strengthens academic collaboration, and facilitates the dissemination of pharmaceutical knowledge to researchers, healthcare professionals, educators, students, and the broader community.
The journal encourages the responsible sharing of published research while respecting authors' rights, research integrity, and applicable licensing conditions.
7. License Limitations and Legal Notices
The CC BY-NC-SA 4.0 license does not eliminate rights or obligations established under applicable copyright and other relevant laws.
Users are not required to comply with the license for material that is already in the public domain or where their intended use is otherwise permitted by applicable legal exceptions or limitations.
The license does not necessarily grant all permissions that may be required for particular uses. Other rights, including privacy, publicity, moral rights, or rights relating to third-party content, may still apply.
The licensed materials are provided without warranties to the extent permitted by applicable law.
Users are encouraged to review the complete licensing terms before reproducing, distributing, translating, or adapting published materials.
8. Licensing Statement
Articles published in The Jurnal Riset Kefarmasian Indonesia are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0), unless otherwise explicitly stated in the individual article's licensing information.
Authors retain copyright and grant the journal the right of first publication.
The license permits non-commercial sharing and adaptation of published materials, provided that appropriate attribution is given and adapted materials are distributed in accordance with the ShareAlike requirements.
Full License Terms:
https://creativecommons.org/licenses/by-nc-sa/4.0/
Official Journal Website:
